Tumour grade does not change between primary and recurrent mammary carcinoma
Authors:
- D.M BarnesDBD.M Barnes
- O.T LampejoOLO.T Lampejo
- M.K EganMEM.K Egan
- P SmithPSP Smith
- 1 March 1998
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 34 (4) , 548-553
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinomaHistopathology, 1996
- Classification of Ductal Carcinoma in Situ of the BreastAdvances in Anatomic Pathology, 1996
- Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancerInternational Journal of Cancer, 1995
- Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumoursEuropean Journal of Cancer, 1993
- Breast cancer treatment and natural history: new insights from results of screeningThe Lancet, 1992
- Expression of c-erbB-2 in in situ and in Adjacent Invasive Ductal Adenocarcinomas of the FemalePathobiology, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Natural history of human breast cancer: Recent data and clinical implicationsBreast Cancer Research and Treatment, 1991
- Regional heterogeneity in breast carcinoma: Thymidine labelling index, steroid hormone receptors, dna ploidyInternational Journal of Cancer, 1991
- An observation of DNA ploidy, histological grade, and immunoreactivity for tumour‐related antigens in primary and metastatic breast carcinomaThe Journal of Pathology, 1989